Bausch + Lomb and Clearside Biomedical: FDA Approved XIPERE™ for Macular Edema Associated with Uveitis

Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™
Bausch + Lomb, a leading global eye health business of Bausch Health Companies (BHC), and Clearside Biomedical (This content is for paid subscribers.

Please click here to subscribe or here to log in.